Bushido Capital US SMID Cap Equity ETF Rating $31.50 -0.07 (-0.22%) As of 10:36 AM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsRatingsShort InterestTrendsBuy This Stock Bushido Capital US SMID Cap Equity ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.RNIN Aggregate RatingHold 2.41Holdings in RNIN have an aggregate rating of Hold based on 345 analyst ratings issued in the past year covering 25 companies (35.1% of the portfolio).RNIN Aggregate Price Target$31.50High Prediction$31.50Average Prediction$31.50Low Prediction$31.50Holdings in RNIN have an aggregate price target of $31.50 and a range of $31.50 to $31.50 covering 25 companies (35.1% of the portfolio).RNIN Consensus Ratings of HoldingsStrong Buy1 Strong Buy rating(s)Buy0 Buy rating(s)Moderate Buy9 Moderate Buy rating(s)Hold13 Hold rating(s)Reduce2 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Bushido Capital US SMID Cap Equity ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 RNIN Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings1.77%OSCROscar Health$17.94-3.4%3.0867 of 5 stars2.00$16.78 -6.5%12Upcoming EarningsAnalyst Forecast1.61%SNXTD SYNNEX$234.85+3.1%4.0893 of 5 stars2.91$197.70 -15.8%11Analyst Forecast1.60%PVHPVH$88.350.0%2.7787 of 5 stars2.35$88.93 0.7%17Dividend AnnouncementAnalyst Downgrade1.55%PTONPeloton Interactive$5.16+0.4%4.5078 of 5 stars2.29$8.60 66.7%14Upcoming Earnings1.54%ETSYEtsy$62.92-1.7%3.066 of 5 stars2.24$70.09 11.4%29Trending NewsAnalyst Downgrade1.48%CROXCrocs$102.94+1.4%1.605 of 5 stars2.13$103.73 0.8%15Earnings Report1.47%VCVisteon$110.23+1.9%4.4023 of 5 stars2.64$124.42 12.9%141.44%MTCHMatch Group$37.65-1.4%4.5089 of 5 stars2.36$37.00 -1.7%14Trending NewsEarnings ReportAnalyst Forecast1.43%MNKDMannKind$2.86+1.8%3.7785 of 5 stars2.60$8.69 203.8%10News CoverageUpcoming Earnings1.43%TPCTutor Perini$97.28+4.9%2.7195 of 5 stars2.25$86.50 -11.1%4Upcoming Earnings1.37%NUTXNutex Health$121.00-17.8%3.9454 of 5 stars2.67$252.50 108.7%3News CoverageEarnings ReportAnalyst Upgrade1.36%CPRXCatalyst Pharmaceuticals$30.86+6.6%4.7689 of 5 stars3.50$34.00 10.2%6Upcoming Earnings1.34%CARTMaplebear$43.74+1.0%4.4477 of 5 stars2.56$51.29 17.3%27Positive NewsUpcoming EarningsAnalyst Downgrade1.33%HRMYHarmony Biosciences$32.34-0.8%4.4606 of 5 stars2.42$42.67 31.9%12News CoveragePositive NewsUpcoming Earnings1.33%TRIPTripAdvisor$11.28-0.4%3.9406 of 5 stars1.94$14.51 28.7%16Upcoming Earnings1.33%CRMDCorMedix$7.73-2.2%3.3887 of 5 stars2.63$15.00 94.0%8Upcoming Earnings1.32%YELPYelp$29.23+2.0%3.1193 of 5 stars1.63$28.50 -2.5%8Upcoming Earnings1.31%INSWInternational Seaways$88.01+3.7%2.5183 of 5 stars2.71$81.00 -8.0%7Upcoming Earnings1.30%TENBTenable$21.02+0.9%4.529 of 5 stars2.40$27.84 32.5%20Earnings ReportAnalyst Revision1.29%TGTXTG Therapeutics$36.10+1.1%3.9581 of 5 stars2.57$50.00 38.5%7Upcoming Earnings1.29%SYMSymbotic$58.06+1.9%2.7329 of 5 stars2.25$65.62 13.0%16News CoverageUpcoming Earnings1.29%DUOLDuolingo$104.03-5.6%4.7764 of 5 stars2.05$195.94 88.4%22Trending NewsEarnings ReportAnalyst ForecastHigh Trading Volume1.29%ONonsemi$102.77+0.7%2.5965 of 5 stars2.45$83.96 -18.3%31Trending NewsEarnings ReportAnalyst ForecastGap DownHigh Trading Volume1.29%PCRXPacira BioSciences$24.79+0.4%3.2077 of 5 stars2.29$29.40 18.6%7Earnings ReportGap Up1.29%DVDoubleVerify$11.47+0.6%4.374 of 5 stars2.50$16.00 39.6%16Upcoming Earnings This page (NASDAQ:RNIN) was last updated on 5/5/2026 by MarketBeat.com Staff. From Our PartnersIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | SponsoredYour book attachedYour Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredThe $1.75T "Backdoor" ticker (NOT Starlink)When the SpaceX IPO launches, most investors will already be too late. The real opportunity isn't the IPO itse...Behind the Markets | SponsoredSell 99% of Your Stocks, Do THIS Instead…Millionaire Trader Exposes: "The Single Stock Income Plan" With over 6,000 stocks on the market to choose ...The Oxford Club | SponsoredTrade this between 9:30 and 10:45 am ESTThe first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...Base Camp Trading | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredElon Unveils AI Passive Income Stream for Millions of AmericansDuring Tesla's last earnings call, Elon Musk outlined a new AI-driven approach he says could generate $30,000-...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bushido Capital US SMID Cap Equity ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Bushido Capital US SMID Cap Equity ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RNIN Stock Alerts